Spinocerebellar ataxia type 12 was not found in Korean Parkinsonian patients

Canadian Journal of Neurological Sciences

Volumn 35, Issue 4, 2008, Pages 488-490

  Cho, Jin Whan ^a,b   Kim, Sung Yeon ^a,c   Park, Sung Sup ^a,c   Jeon, Beom S ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTIDINE; PHOSPHOPROTEIN PHOSPHATASE 2A; TRINUCLEOTIDE; URIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PRIORITY JOURNAL; SCHOOL CHILD; SHY DRAGER SYNDROME; SPINOCEREBELLAR ATAXIA TYPE 12; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

EID: 55049083785     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009161     Document Type: Article

References (20)

1. Manto MU. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum. 2005;4:2-6.
2. Gwinn-Hardy K, Chen JY, Liu HC, Liu TY, Boss M, Seltzer W, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology. 2000;55:800-5.
3. Gwinn-Hardy K, Singleton A, O'Suilleabhain P, Boss M, Nicholl D, Adam A, et al. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol. 2001;58:296-9.
4. Furtado S, Farrer M, Tsuboi Y, Klimek ML, de la Fuente-Fernández R, Hussey J, et al. SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology. 2002;59:1625-7.
5. Payami H, Nutt J, Gancher S, Bird T, McNeal MG, Seltzer WK, et al. SCA2 may present as levodopa-responsive parkinsonism. Mov Disord. 2003;18:425-9.
6. Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol. 2004;61:35-8.
7. Shan DE, Liu RS, Sun CM, Lee SJ, Liao KK, Soong BW. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications. Mov Disord. 2004;19:1357-60.
8. Wilkins A, Brown JM, Barker RA. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report. Mov Disord. 2004;19:593-5.
9. Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet. 2004: 65: 209-214.
10. Simon-Sanchez J, Hanson M, Singleton A, Hernandez D, McInerney A, Nussbaum R, et al. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease. Neurosci Lett. 2005;382:191-4.
11. Lim SW, Zhao Y, Chua E, Law HY, Yuen Y, Pavanni R, et al. Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease. Neurosci Lett. 2006;403:11-14.
12. Modoni A, Contarino MF, Bentivoglio AR, Tabolacci E, Santoro M, Calcagni ML, et al. Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord. 2007;22:324-7.
13. Kim JM, Hong S, Kim GP, Choi YJ, Kim YK, Park SS, et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol. 2007;64:1510-8.
14. Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet. 1999;23:391-2.
15. Bahl S, Virdi K, Mittal U, Sachdeva MP, Kalla AK, Holmes SE, et al. Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet. 2005;69:528-34.
16. Fujigasaki H, Verma IC, Camuzat A, Margolis RL, Zander C, Lebre AS, et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol. 2001;49:117-21.
17. Holmes SE, O'Hearn E, Margolis RL. Why is SCA12 different from other SCAs? Cytogenet Genome Res. 2003;100:189-97.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-4.
19. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94-8.
20. Wu YR, Fung HC, Lee-Chen GJ, Gwinn-Hardy K, Ro LS, Chen ST, et al. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm. 2005;112:539-46.